Covid-19

#Clinical trials #Covid-19 #Healthcare #Public health

Interview: Delivering smart clinical trials for better health 

Following the launch of Protas, an organisation which was launched on January 24, 2022, DDW Editorial Assistant Megan Thomas interviews Protas Chief Executive, Professor Sir Martin Landray, an epidemiologist and physician who has over 20 years’ experience of leading large, randomised clinical trials and has most recently been leading the… Read More

#Covid-19 #Exclusive Content #News #Opinion

#Covid-19 #Novavax

Serum Institute of India enters adolescents Covid-19 vaccine market  

The recent approval of Novavax’s protein-based Covid-19 vaccine for adolescents aged 12-18 years will help its partner, the Serum Institute of India (SII) enter the adolescents’ market, according to GlobalData.   Novavax’s Covid-19 vaccine was granted emergency use authorisation by the Drugs Controller General of India (DCGI) in… Read More

#Covid-19 #News

#Covid variants #Covid-19 #Omicron

Are we getting a lead on Omicron subvariant? Study says yes 

New preclinical authentic ‘live’ virus data from Washington University School of Medicine demonstrated that Evusheld (tixagevimab co-packaged with cilgavimab) retains potent neutralising activity against the emerging and highly transmissible Omicron SARS-CoV-2 BA.2 subvariant.1 The data also showed that Evusheld retains activity against Omicron BA.1 and BA.1.1.1. The findings were… Read More

#News #Trending News

#Biopharmaceuticals #Covid-19

Needle-free intranasal Covid-19 vaccine gets green-light for trials 

Oragenics has entered into an agreement with KBI Biopharma for the process transfer, process optimisation and cGMP manufacturing of the company’s intranasal vaccine candidate NT-CoV2-1, which is expressed in a proprietary CHO cell line.   Background  Oragenics previously demonstrated robust immune response and reduction of SARS-CoV-2… Read More

#News #Trending News

#Covid-19 #Immunology / Virology & Vaccines #Market reporting

Was England’s vaccine programme value for money?

This most recent report by the Comptroller and Auditor General examines the rollout of the Covid-19 vaccination programme in England up to the end of October 2021, focusing on events up to the end of October 2021 and assessing whether the programme is well placed to meet its objectives… Read More

#Covid-19 #News

#Biopharmaceuticals #Covid-19 #Drug discovery #Pharmaceutical #Therapeutics #Women in STEM

International Women’s Day: Female achievement in drug discovery

The theme for International Women’s Day 2022 is ‘Break the Bias’, in which society is encouraged to celebrate women's achievements, in turn raising awareness against bias and inspiring positive action for equality. Though the initiative is interdisciplinary, the drug discovery, life science and pharmaceutical world boasts many achievements of this… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trending News

#Covid-19 #Long Covid #Novel therapeutics #Omicron

Is this plant-based therapy a Covid cure? 

The startup company Novel Concepts Medical has announced breakthroughs in its research of Covid-19, which include stopping Covid-19, the Omicron Variant, and long Covid-19 symptoms, including memory loss.   The treatment  Its novel plant-based treatment has resulted in successfully inhibiting the Covid-19 Omicron variant and blocking… Read More

#News

#Covid-19 #Public health #Research study

SARS-CoV-2 human challenge studies are safe in healthy young adults 

Open Orphan has released the results from its Covid-19 characterisation study, which was a partnership between hVIVO, Imperial College London, the Vaccine Taskforce and Department of Health and Social Care (DHSC), and the Royal Free London NHS Foundation Trust. The results from this study show that a SARS-CoV-2 human… Read More

#News

#Covid-19 #FDA #Immunology / Virology & Vaccines #Moderna

Moderna receives full FDA approval for Covid-19 vaccine Spikevax 

The US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Moderna’s Spikevax, an mRNA vaccine for prevention of Covid-19 in individuals 18 years of age and older.  Official comments   “Our Covid-19 vaccine has been administered to hundreds of millions of… Read More

#News

#Covid booster #Covid variants #Covid-19 #Immunology / Virology & Vaccines #Moderna #mRNA #Omicron

Moderna begins Omicron booster trial and presents durability data 

Moderna has dosed the first participant in a Phase II study of the company’s Omicron-specific booster candidate (mRNA-1273.529). Additionally, Moderna announced the publication of neutralising antibody data against the Omicron variant six months following a booster dose in The New England Journal of Medicine.   The mRNA-1273.529 trial  This extension… Read More

#News #Trending News

#Covid booster #Covid-19 #FDA #Immunology / Virology & Vaccines #mRNA

Additional dose of Covid-19 vaccine is safe, says US trial 

A study sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, suggests that an additional dose of a Covid-19 vaccine is safe in adults who had previously received a full regimen of any of three Covid-19 vaccines granted Emergency Use Authorization… Read More

#News #Trending News

#Covid-19 #Diagnostics #PCR #Screening

App note: SARS-CoV-2 detection workflow in wastewater

Monitoring wastewater for SARS-CoV-2 – or Coronavirus as it is more commonly known – can be a valuable data resource for an effective Covid-19 management. However, there are several challenges involved in detecting biological parameters in wastewater. Fortunately, there are also several solutions available to overcome them. Wastewater can be… Read More

#News

Pills
#Approvals #Covid-19 #Marketing approval authorisation

NICE expands guidance for AstraZeneca’s hyperkalaemia drug

The National Institute for Health and Care Excellence (NICE) has updated Technology Appraisal Guidance (TAG) TA599 for AstraZeneca’s Lokelma (sodium zirconium cyclosilicate [SZC]) in the treatment of adult patients with hyperkalaemia in England, Wales, and Northern Ireland.   Context   This guidance update follows the removal of the previous commercial arrangement, meaning… Read More

#News

#Covid booster #Covid variants #Covid-19 #Immunology / Virology & Vaccines #Omicron

Covid-19 booster provides good antibody protection against Omicron 

A third ‘booster’ dose of Covid-19 vaccine successfully raises antibody levels that neutralise the Omicron variant, according to laboratory findings from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published as a Research letter in The Lancet.   The results  Researchers found that antibodies generated in people… Read More

#News

#Comment #Covid-19 #Drug discovery #Podcast

From here to there: What lies ahead for drug discovery – podcast

This is the latest episode of the free DDW podcast, “From here to there: What lies ahead for drug discovery”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW and read aloud by Megan Thomas. The articles are called “The complexity of disease… Read More

#News